![Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity | Clinical Drug Investigation Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity | Clinical Drug Investigation](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F11592990-000000000-00000/MediaObjects/40261_2012_31070001_Tab2.jpg)
Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity | Clinical Drug Investigation
![Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity | Clinical Drug Investigation Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity | Clinical Drug Investigation](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F11592990-000000000-00000/MediaObjects/40261_2012_31070001_Tab1.jpg)
Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity | Clinical Drug Investigation
![Pancreatic enzymes prepared in bicarbonate solution for administration through enteral feeding tubes. | Semantic Scholar Pancreatic enzymes prepared in bicarbonate solution for administration through enteral feeding tubes. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d39310aef7155335fe9ac150e5899ad1d8648fd8/3-Table2-1.png)